News from the FDA/CDC

Many children with COVID-19 don’t have cough or fever


 

FROM MMWR

The characteristic COVID-19 symptoms of cough, fever, and shortness of breath are less common in children than adults, according to the Centers for Disease and Prevention Control.

Leading signs and symptoms of COVID-19: Children vs. adults

Among pediatric patients younger than 18 years in the United States, 73% had at least one of the trio of symptoms, compared with 93% of adults aged 18-64, noted Lucy A. McNamara, PhD, and the CDC’s COVID-19 response team, based on a preliminary analysis of the 149,082 cases reported as of April 2.

By a small margin, fever – present in 58% of pediatric patients – was the most common sign or symptom of COVID-19, compared with cough at 54% and shortness of breath in 13%. In adults, cough (81%) was seen most often, followed by fever (71%) and shortness of breath (43%), the investigators reported in the MMWR.

In both children and adults, headache and myalgia were more common than shortness of breath, as was sore throat in children, the team added.

“These findings are largely consistent with a report on pediatric COVID-19 patients aged <16 years in China, which found that only 41.5% of pediatric patients had fever [and] 48.5% had cough,” they wrote.

The CDC analysis of pediatric patients was limited by its small sample size, with data on signs and symptoms available for only 11% (291) of the 2,572 children known to have COVID-19 as of April 2. The adult population included 10,944 individuals, who represented 9.6% of the 113,985 U.S. patients aged 18-65, the response team said.

“As the number of COVID-19 cases continues to increase in many parts of the United States, it will be important to adapt COVID-19 surveillance strategies to maintain collection of critical case information without overburdening jurisdiction health departments,” they said.

SOURCE: McNamara LA et al. MMWR 2020 Apr 6;69(early release):1-5.

Recommended Reading

First report of MM patient successfully treated for COVID-19 with tocilizumab
MDedge Hematology and Oncology
Flu activity down from its third peak of the season, COVID-19 still a factor
MDedge Hematology and Oncology
‘Brutal’ plan to restrict palliative radiation during pandemic
MDedge Hematology and Oncology
COVID-19 less severe in children, yet questions for pediatricians remain
MDedge Hematology and Oncology
Coronavirus on fabric: What you should know
MDedge Hematology and Oncology
A decade of telemedicine policy has advanced in just 2 weeks
MDedge Hematology and Oncology
Is protocol-driven COVID-19 respiratory therapy doing more harm than good?
MDedge Hematology and Oncology
Which of the changes that coronavirus has forced upon us will remain?
MDedge Hematology and Oncology
Practicing solo and feeling grateful – despite COVID-19
MDedge Hematology and Oncology
AAP issues guidance on managing infants born to mothers with COVID-19
MDedge Hematology and Oncology